August 21, 2009
BY EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| Re: | Monogram Biosciences, Inc. |
Post-Effective Amendment No.1 to
Registration Statement on Form S-3
Filed February 13, 2009
File No. 333-157294
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended, Monogram Biosciences, Inc. (the “Company”) hereby applies for withdrawal of its Post-Effective Amendment No.1, filed August 17, 2009, to the registration statement on Form S-3 (Registration Statement No. 333-157294), which was filed with the Commission on February 13, 2009, together with all exhibits thereto (the “Registration Statement”). The Company does not intend to conduct the offering of shares of common stock contemplated in the Registration Statement because it has been acquired by Laboratory Corporation of America Holdings (“LabCorp”) and is now a wholly-owned subsidiary of LabCorp. No securities were sold in connection with the Registration Statement.
The Company hereby respectfully requests that an order granting the withdrawal of the Post-Effective Amendment No. 1 to the Registration Statement be issued by the Commission as soon as reasonably possible. If you have any questions concerning this request for withdrawal, please contact the Company’s outside counsel, John H. Booher at (410) 659-2790.
| Sincerely, | ||
| Monogram Biosciences, Inc. | ||
| By: | /s/ F. Samuel Eberts III | |
| Name: | F. Samuel Eberts III | |
| Title: | President | |